Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sickle cell vaso-occlusion.

Elaine Y Chiang1, Paul S Frenette

  • 1Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

Hematology/Oncology Clinics of North America
|October 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct prokaryotic gut microbiome and proviral-immune axes of pathophysiology in Sickle Cell Disease.

bioRxiv : the preprint server for biology·2026
Same author

Higher aged neutrophils and differential inflammatory profiles in sickle cell disease patients on chronic transfusion therapy versus those on hydroxyurea.

Frontiers in immunology·2025
Same author

Haematopoietic stem cell number is not solely defined by niche availability.

Nature·2025
Same author

Regulation of the hematopoietic stem cell pool by C-Kit-associated trogocytosis.

Science (New York, N.Y.)·2024
Same author

Thrombopoietin mimetic stimulates bone marrow vascular and stromal niches to mitigate acute radiation syndrome.

Stem cell research & therapy·2024
Same author

Thrombopoietin mimetic stimulates bone marrow vascular and stromal niches to mitigate acute radiation syndrome.

Research square·2024

Sickle cell vaso-occlusion involves complex interactions between sickle erythrocytes and other cells, leading to blocked blood flow. Further animal studies are crucial for developing effective sickle cell disease therapies.

Area of Science:

  • Hematology
  • Vascular Biology
  • Cellular Interactions

Background:

  • Vaso-occlusion in sickle cell disease is a complex process.
  • It involves interactions between sickle erythrocytes (SSRBCs), leukocytes, endothelial cells, and plasma proteins.
  • Endothelial activation, driven by SSRBCs, is a key initiating factor.

Purpose of the Study:

  • To review the evolution of the vaso-occlusion model in sickle cell disease.
  • To highlight the complex, multi-step interactions involved.
  • To emphasize the need for further in vivo research.

Main Methods:

  • Review of existing literature on vaso-occlusion mechanisms.
  • Analysis of the interplay between cellular and molecular factors.
  • Discussion of the limitations of current models.

Related Experiment Videos

Main Results:

  • The vaso-occlusion model has progressed from simple polymerization concepts to a complex schema.
  • Multistep, heterogeneous, and interdependent interactions are central to vaso-occlusion.
  • Endothelial activation is a critical early event.

Conclusions:

  • Understanding the complexity of vaso-occlusion is essential.
  • In vivo studies in sickle cell animal models are vital for advancing knowledge.
  • Further research will drive the development of novel therapeutic strategies for sickle cell disease.